TAccording to a strategy published by Warren Buffett, Valida is the highest-ranked healthcare company in the patient investment model. This strategy requires long-term, predictable profitability and low-debt companies to trade at affordable prices.

MEDIFAST INC (MED) is a medium-sized growth stock in the biotechnology and pharmaceutical industry. Based on Warren Buffett, according to our strategy, the rating is 99% based on the company’s basic principles and stock evaluation. A score of 80% or more typically indicates a certain interest in the stock and a score of more than 90% typically indicates a strong interest.

Company Description: Medifast, Inc. Produces, distributes and distributes weight loss, weight management and healthy lifestyle products and other consumer health and nutrition products. The company’s products include weight loss, weight management and a healthy diet, snacks, water products and vitamins. The business segments include Opeeta, Medifast Live, Frances Medifast Weight Control Centers (MCC) and Medifast Wholesale. Optavia is part of the company’s private coaching staff, which provides training and support to Opetavia coaches. Medifast Direct allows customers to order Medifast products directly through the website or in-house call center directly to the consumer business unit. MWCC’s business unit sells products through franchises and vendors that offer structured programs and a team of experts to help customers achieve weight loss and weight management success in central locations.

The following table summarizes that the stock meets each of the strategic tests. Not all of the criteria in the table below are equally weighted or neutral, but the table strategy provides a brief overview of the strengths and weaknesses of security in the context of the strategy criteria.

Revenue Forecast – Pass
Debt Service – Pass
Return in equality Pass
Return to Total Capital: Pass
Free cash flow; Pass
Use of reserved income – Pass
Redistribution: Neutral
Return stage: Pass
Expected Return: Pass

MEDIFAST INC Detailed Analysis

Full Guru Analysis for MED>

Full Factory Report for MED>

CHEMED CORPORATION (CHE) is a medium-sized capital stockpile in the healthcare equipment industry. Based on Warren Buffett, according to our strategy, the rating is 93% based on the company’s basics and stock price. A score of 80% or more typically indicates a certain interest in the stock and a score of more than 90% typically shows strong interest.

Company Description: Chemed Corporation buys, operates and produces sub-companies engaged in various business activities. The company operates in two divisions: the VITAS division (VITAS) and the Roto-Rooter division. The company’s VITAS provides hospice and palliative care services through a network of physicians, registered nurses, home health assistants, social workers, priests and volunteers. Vitas is primarily a provider of hospice services in the small, non-profit, community-based hospital industry. Vitas provides hospice care for Medicare users who participate in these managed care programs. The VITAS business unit operates in the state of Florida. The Roto-Rotter unit provides water, sewerage, water renovation and other related services to residential and commercial customers.

The following table summarizes that the stock meets each of the strategic tests. Not all of the criteria in the table below are equally weighted or neutral, but the table strategy provides a brief overview of the strengths and weaknesses of security in the context of the strategy criteria.

Revenue Forecast – Pass
Debt Service – Pass
Return in equality Pass
Return to Total Capital: Pass
Free cash flow; Pass
Use of reserved income – Pass
Redistribution: Pass
Return stage: Pass
Expected Return: Pass

Detailed analysis of CHEMED Corporation

Full Guru Analysis for CHE>

Full Factory Report for CHE>

USANA HEALTH SCIENCES, INC. (USNA) is a low-capital asset in the biotechnology and pharmaceutical industry. Based on Warren Buffett, according to our strategy, the rating is 93% based on the company’s basics and stock price. A score of 80% or more typically indicates a certain interest in the stock and a score of more than 90% typically indicates a strong interest.

Company Description: USANA Health Sciences, Inc. Produces and manufactures science-based nutrition and personal care products. The company operates directly in two geographic regions: the United States and Europe, and the Asia-Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines are USA: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: A: Its USA and Nutritional Basics product line includes vitamins and minerals that are the basis of a comprehensive diet for every age group, starting at approximately one year of age. Its Facilitator product line includes targeted supplements designed to meet the health and nutritional needs of individuals. Its Emotions: A beautiful science product line includes personal care products that support skin and hair by providing environmentally friendly food, moisture and protection.

The following table summarizes that the stock meets each of the strategic tests. Not all of the criteria in the table below are equally weighted or neutral, but the table strategy provides a brief overview of the strengths and weaknesses of security in the context of the strategy criteria.

Revenue Forecast – Pass
Debt Service – Pass
Return in equality Pass
Return to Total Capital: Pass
Free cash flow; Pass
Use of reserved income – Pass
Redistribution: Pass
Return stage: Pass
Expected Return: Pass

USANA HEALTH SCIENCES, INC Detailed Analysis.

For full analysis of USA>

Full Factory Report for USNA>

ALIGN TECHNOLOGY, INC. ALGN is a large-cap growth stock in the medical equipment and supplies industry. Based on Warren Buffett, our strategy is based on 86% of the company’s core values ​​and stock evaluation. A score of 80% or more typically indicates a certain interest in the stock and a score of more than 90% typically indicates a strong interest.

Company Description: Modifies, manufactures, manufactures, and promotes technology Invisalign is a clear developer and ITER scanner and services for dentistry, and computer-assisted design and computer-assisted production (CAD / CAM) software for dental laboratories and dentists. It works in two parts – clear the layout section and image systems and the CAD / CAM services (systems and services) section. The Clear Aligner component includes the Invisalign System, which includes Invisalign Full, Toddler & Assistant (Universal Products), Invisible Medium, Easy and Express Packages and Invitation Healing (Non-Compliant Products) and Vivera Retention, to treat disobedience with training and auxiliary products. (Not the case). The Systems and Services section includes hardware platform and recovery software or bone software options, orthodox services and auxiliary products, and exocad CAD / CAM software solutions.

The following table summarizes that the stock meets each of the strategic tests. Not all of the criteria in the table below are equally weighted or neutral, but the table strategy provides a brief overview of the strengths and weaknesses of security in the context of the strategy criteria.

Revenue Forecast – Pass
Debt Service – Pass
Return in equality Failed
Return to Total Capital: Pass
Free cash flow; Pass
Use of reserved income – Pass
Redistribution: Pass
Return stage: Pass
Expected Return: Pass

Detailed analysis of ALIGN TECHNOLOGY, INC

Full Guru Analysis for ALGN>

Full Factory Report for ALGN>

CORVEL CORPORATION (CRVL) is a medium-sized stockpile in the healthcare industry industry. Based on Warren Buffett, according to our strategy, the rating is 72% based on the company’s basic foundations and stock price. A score of 80% or more typically indicates a certain interest in the stock and a score of more than 90% typically indicates a strong interest.

Company Description – Corville is a provider of workers’ compensation solutions to employers, third-party managers, insurance companies and government agencies. The company offers its services as a package solution, which includes claim management, additional services such as independent services or existing customers. The company offers its services as a package solution, which includes claim management, additional services such as independent services or existing customers. The company’s network solutions include accounting evaluation, PPO management, professional evaluation, provider reimbursement, pharmacy services, direct care services, pharmaceutical solutions and cleaning services. The company’s patient management services include claim management, case management, 24/7 nursing trim, use management, occupational rehabilitation, life care planning, disability management, liability management and self-complaint management.

The following table summarizes that the stock meets each of the strategic tests. Not all of the criteria in the table below are equally weighted or neutral, but the table strategy provides a brief overview of the strengths and weaknesses of security in the context of the strategy criteria.

Revenue Forecast – Pass
Debt Service – Pass
Return in equality Pass
Return to Total Capital: Pass
Free cash flow; Pass
Use of reserved income – Failed
Redistribution: Pass
Return stage: Pass
Expected Return: Failed

CORVEL Corporation detailed analysis

Full Guru Analysis for CRVL>

Full factory report for CRVL>

More details on Valida Warren Buffett’s strategy

Warren Buffett stock ideas

About Warren Buffett – Warren Buffett is considered by many to be the greatest investor of all time. As chairman of the Berkshire Hatway, Buffett has consistently surpassed the S&P 500 for decades, and in the process has become one of the richest men in the world. (Forbes put his net worth at $ 37 billion.) Although rich, Buffett is known for his modest lifestyle. According to Forbes, Gray Stuco Nebraka, which he bought for $ 31,500 50 years ago, is home to his favorite Middle West street and easy-to-enjoy – cherry coke, a good burger and a good book. At the top of the list: Well-registered.

About Valida – Valida is an investment research service that follows the published strategies of investment myths. Validia provides stock analysis and model portfolio based on market-leading gurus, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zieg. Click here for more information about Validea

The views and opinions expressed herein are the views and opinions of the author and, of course, Nasdaq, Inc.